Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

getz healthcare pty ltd - 40796 - hyperthermia applicator, heated fluid, intracorporeal - disposable sets are to be used in conjunction with the pump for the purpose of raising the temperature of the thoracic or peritoneal cavity to the desired target temperature by continuously lavaging the cavity with circulating warmed sterile solution, according to a protocol to be selected by the physician.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

olympus australia pty ltd - 40782 - hyperthermia system, radio frequency - the trolley permits mobile installation of equipment and accessories for carrying out radiofrequency induced thermotherapy (rfitt).

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

soma lasers australia - 40781 - hyperthermia system, ultrasound - non invasive dermatological therapeutic device intended to be used for patients who have ptosis, psoriasis and for treatment of the wrinkle, tightening and lifting

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

getz healthcare pty ltd - 40781 - hyperthermia system, ultrasound - accessories to exablate 4000 system (type 1.0 and 1.1) that are used for treatment of neurological disorders (essential tremors, tremor dominant idiopathic parkinson?s disease ? unilateral) and neuropathic pain in the brain by heat induced focusing using ultrasound energy under mr planning and thermal imaging control.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

r2 pharma solutions pty ltd - 47103 - hyperthermia device, insect bite/sting - heat it is a non-sterile, reusable device used for the external treatment of insect bites or stings (e.g., from gnats, mosquitoes, wasps, hornets, horseflies) through the application of concentrated heat. the heat (around 51 degrees celsius) works to minimize or prevent itching, and may prevent subsequent swelling. device is used in conjunction with a suitable smartphone and can be controlled using mobile application.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

fitzone solutions pty ltd - 47103 - hyperthermia device, insect bite/sting - the insect bite healer is intended for relieving itching and swelling caused by insect bites or stings by applying heat (local hyperthermia)

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - tisagenlecleucel, quantity: 1200000 cells - suspension - excipient ingredients: glucose; sodium; chloride; albumin; aluminium; magnesium; dimethyl sulfoxide; gluconic acid; acetate; caprylate; furfural; dimethyl sulfone; dextran 40; potassium; n-acetyltryptophan - cellular therapies - kymriah is a genetically modified autologous immunocellular therapy indicated for the treatment of paediatric and young adult patients up to 25 years of age with b-cell precursor acute lymphoblastic leukaemia (all) that is refractory, in relapse post-transplant, or in second or later relapse.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - tisagenlecleucel, quantity: 60000000 cells - suspension - excipient ingredients: n-acetyltryptophan; albumin; acetate; gluconic acid; sodium; magnesium; potassium; dimethyl sulfoxide; glucose; aluminium; caprylate; dextran 40; furfural; dimethyl sulfone; chloride - cellular therapies - kymriah is a genetically modified autologous immunocellular therapy indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy. kymriah is not indicated for patients with primary central nervous system lymphoma.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

clinical laserthermia systems asia pacific pte ltd - radiology / imaging - the tranberg mobile laser unit is intended for thermal ablation of soft tissue pathological lesions. the device is intended to be used by trained medical health care professionals in hospitals or in outpatient clinics. it can be used for tumor control and/or symptomatic relief and/or restoring of physiological functions when other treatment options are not eligible or effective: • in the liver for thermal ablation of soft tissue pathological lesions (tumors) in adults • in the prostate for thermal ablation of soft tissue pathological lesions (localized low or intermediate risk prostate cancer with significant life expectancy or benign prostate hyperplasia, bph) in adults.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

rem systems pty ltd - 47761 - intravascular/intracavitary-circulation hyperthermia system set - disposable devices intended to recirculate, filtrate and perfuse clear solutions, also enriched with chemotherapeutic agents, in the thoracic or abdominal cavity. the devices are intended for use up to 6 hours, in regional cancer hyperthermic therapies following surgical reduction.